Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Belumosudil-R	7	51
Total, all-cause mortality	BSC-R	3	24
Total, all-cause mortality	Belumosudil-WC	9	68
Total, all-cause mortality	BSC-NC	1	24
Total, all-cause mortality	Total	10	75
Total, other adverse events	Belumosudil-R	50	51
Total, other adverse events	BSC-R	23	24
Total, other adverse events	Belumosudil-WC	67	68
Total, other adverse events	BSC-NC	19	24
Total, other adverse events	Total	73	75
Total, serious adverse events	Belumosudil-R	29	51
Total, serious adverse events	BSC-R	10	24
Total, serious adverse events	Belumosudil-WC	38	68
Total, serious adverse events	BSC-NC	4	24
Total, serious adverse events	Total	39	75

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02688647/event-totals